Association of a polymorphism in the dopamine‐transporter gene with parkinson's disease
Identifieur interne : 003203 ( Istex/Corpus ); précédent : 003202; suivant : 003204Association of a polymorphism in the dopamine‐transporter gene with parkinson's disease
Auteurs : le Couteur ; Peter W. Leighton ; Sally J. Mccann ; Susan M. PondSource :
- Movement Disorders [ 0885-3185 ] ; 1997-09.
English descriptors
Abstract
The presynaptic dopamine transporter in nigral dopaminergic neurons confers susceptibility to the cytotoxic effects of the neurotoxic metabolite of 1‐methy1‐4‐phenyl‐1,2,3,6‐tetrahydropyridine. Polymorphisms in the dopamine transporter might influence the susceptibility to such toxins. Therefore, we investigated whether a polymorphic region in the 3′‐untranslated region of the dopamine‐transporter gene is associated with idiopathic Parkinson's disease (PD). The frequency distribution of the alleles was significantly different between the patients (n = 100) and controls (n = 200, p < 0.05). The rare 11‐copy allele was more common in the patients (odds ratio = 10.2, 95% confidence interval = 1.2‐87.9, p < 0.025). The susceptibility of some people to PD may be conferred by polymorphisms in the dopamine‐transporter gene that could lead to increased cellular accumulation of neurotoxic compounds in dopaminergic neurons.
Url:
DOI: 10.1002/mds.870120523
Links to Exploration step
ISTEX:6F1D130494B9C0301723AFA278CEBA9DC1FE54B9Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Association of a polymorphism in the dopamine‐transporter gene with parkinson's disease</title><author><name sortKey="Le Couteur" sort="Le Couteur" uniqKey="Le Couteur" last="Le Couteur">le Couteur</name><affiliation><mods:affiliation>University of Queensland, Department of Medicine, Princess Alexandra Hospital, Woolloongabba, Australia</mods:affiliation></affiliation></author><author><name sortKey="Leighton, Peter W" sort="Leighton, Peter W" uniqKey="Leighton P" first="Peter W." last="Leighton">Peter W. Leighton</name><affiliation><mods:affiliation>University of Queensland, Department of Medicine, Princess Alexandra Hospital, Woolloongabba, Australia</mods:affiliation></affiliation></author><author><name sortKey="Mccann, Sally J" sort="Mccann, Sally J" uniqKey="Mccann S" first="Sally J." last="Mccann">Sally J. Mccann</name><affiliation><mods:affiliation>University of Queensland, Department of Medicine, Princess Alexandra Hospital, Woolloongabba, Australia</mods:affiliation></affiliation></author><author><name sortKey="Pond, Susan M" sort="Pond, Susan M" uniqKey="Pond S" first="Susan M." last="Pond">Susan M. Pond</name><affiliation><mods:affiliation>University of Queensland, Department of Medicine, Princess Alexandra Hospital, Woolloongabba, Australia</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:6F1D130494B9C0301723AFA278CEBA9DC1FE54B9</idno><date when="1997" year="1997">1997</date><idno type="doi">10.1002/mds.870120523</idno><idno type="url">https://api.istex.fr/document/6F1D130494B9C0301723AFA278CEBA9DC1FE54B9/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">003203</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Association of a polymorphism in the dopamine‐transporter gene with parkinson's disease</title><author><name sortKey="Le Couteur" sort="Le Couteur" uniqKey="Le Couteur" last="Le Couteur">le Couteur</name><affiliation><mods:affiliation>University of Queensland, Department of Medicine, Princess Alexandra Hospital, Woolloongabba, Australia</mods:affiliation></affiliation></author><author><name sortKey="Leighton, Peter W" sort="Leighton, Peter W" uniqKey="Leighton P" first="Peter W." last="Leighton">Peter W. Leighton</name><affiliation><mods:affiliation>University of Queensland, Department of Medicine, Princess Alexandra Hospital, Woolloongabba, Australia</mods:affiliation></affiliation></author><author><name sortKey="Mccann, Sally J" sort="Mccann, Sally J" uniqKey="Mccann S" first="Sally J." last="Mccann">Sally J. Mccann</name><affiliation><mods:affiliation>University of Queensland, Department of Medicine, Princess Alexandra Hospital, Woolloongabba, Australia</mods:affiliation></affiliation></author><author><name sortKey="Pond, Susan M" sort="Pond, Susan M" uniqKey="Pond S" first="Susan M." last="Pond">Susan M. Pond</name><affiliation><mods:affiliation>University of Queensland, Department of Medicine, Princess Alexandra Hospital, Woolloongabba, Australia</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="sub">Official Journal of the Movement Disorder Society</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="1997-09">1997-09</date><biblScope unit="vol">12</biblScope><biblScope unit="issue">5</biblScope><biblScope unit="page" from="760">760</biblScope><biblScope unit="page" to="763">763</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">6F1D130494B9C0301723AFA278CEBA9DC1FE54B9</idno><idno type="DOI">10.1002/mds.870120523</idno><idno type="ArticleID">MDS870120523</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Dopamine transporter</term><term>Parkinson's disease</term><term>Polymorphism</term><term>Variable‐number tandem repeat</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The presynaptic dopamine transporter in nigral dopaminergic neurons confers susceptibility to the cytotoxic effects of the neurotoxic metabolite of 1‐methy1‐4‐phenyl‐1,2,3,6‐tetrahydropyridine. Polymorphisms in the dopamine transporter might influence the susceptibility to such toxins. Therefore, we investigated whether a polymorphic region in the 3′‐untranslated region of the dopamine‐transporter gene is associated with idiopathic Parkinson's disease (PD). The frequency distribution of the alleles was significantly different between the patients (n = 100) and controls (n = 200, p < 0.05). The rare 11‐copy allele was more common in the patients (odds ratio = 10.2, 95% confidence interval = 1.2‐87.9, p < 0.025). The susceptibility of some people to PD may be conferred by polymorphisms in the dopamine‐transporter gene that could lead to increased cellular accumulation of neurotoxic compounds in dopaminergic neurons.</div></front></TEI><istex><corpusName>wiley</corpusName><author><json:item><name>Dr. le Couteur</name><affiliations><json:string>University of Queensland, Department of Medicine, Princess Alexandra Hospital, Woolloongabba, Australia</json:string></affiliations></json:item><json:item><name>Peter W. Leighton</name><affiliations><json:string>University of Queensland, Department of Medicine, Princess Alexandra Hospital, Woolloongabba, Australia</json:string></affiliations></json:item><json:item><name>Sally J. McCann</name><affiliations><json:string>University of Queensland, Department of Medicine, Princess Alexandra Hospital, Woolloongabba, Australia</json:string></affiliations></json:item><json:item><name>Susan M. Pond</name><affiliations><json:string>University of Queensland, Department of Medicine, Princess Alexandra Hospital, Woolloongabba, Australia</json:string></affiliations></json:item></author><subject><json:item><lang><json:string>eng</json:string></lang><value>Parkinson's disease</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>Dopamine transporter</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>Polymorphism</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>Variable‐number tandem repeat</value></json:item></subject><language><json:string>eng</json:string></language><abstract>The presynaptic dopamine transporter in nigral dopaminergic neurons confers susceptibility to the cytotoxic effects of the neurotoxic metabolite of 1‐methy1‐4‐phenyl‐1,2,3,6‐tetrahydropyridine. Polymorphisms in the dopamine transporter might influence the susceptibility to such toxins. Therefore, we investigated whether a polymorphic region in the 3′‐untranslated region of the dopamine‐transporter gene is associated with idiopathic Parkinson's disease (PD). The frequency distribution of the alleles was significantly different between the patients (n = 100) and controls (n = 200, p > 0.05). The rare 11‐copy allele was more common in the patients (odds ratio = 10.2, 95% confidence interval = 1.2‐87.9, p > 0.025). The susceptibility of some people to PD may be conferred by polymorphisms in the dopamine‐transporter gene that could lead to increased cellular accumulation of neurotoxic compounds in dopaminergic neurons.</abstract><qualityIndicators><score>3.673</score><pdfVersion>1.3</pdfVersion><pdfPageSize>612 x 827.759 pts</pdfPageSize><refBibsNative>true</refBibsNative><abstractCharCount>927</abstractCharCount><pdfWordCount>2137</pdfWordCount><pdfCharCount>13862</pdfCharCount><pdfPageCount>4</pdfPageCount><abstractWordCount>128</abstractWordCount></qualityIndicators><title>Association of a polymorphism in the dopamine‐transporter gene with parkinson's disease</title><genre><json:string>Serial article</json:string></genre><host><volume>12</volume><pages><total>4</total><last>763</last><first>760</first></pages><issn><json:string>0885-3185</json:string></issn><issue>5</issue><subject><json:item><value>Brief Report</value></json:item></subject><genre></genre><language><json:string>unknown</json:string></language><title>Movement Disorders</title><doi><json:string>10.1002/(ISSN)1531-8257</json:string></doi></host><publicationDate>1997</publicationDate><copyrightDate>1997</copyrightDate><doi><json:string>10.1002/mds.870120523</json:string></doi><id>6F1D130494B9C0301723AFA278CEBA9DC1FE54B9</id><fulltext><json:item><original>true</original><mimetype>application/pdf</mimetype><extension>pdf</extension><uri>https://api.istex.fr/document/6F1D130494B9C0301723AFA278CEBA9DC1FE54B9/fulltext/pdf</uri></json:item><json:item><original>false</original><mimetype>application/zip</mimetype><extension>zip</extension><uri>https://api.istex.fr/document/6F1D130494B9C0301723AFA278CEBA9DC1FE54B9/fulltext/zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/document/6F1D130494B9C0301723AFA278CEBA9DC1FE54B9/fulltext/tei"><teiHeader type="text"><fileDesc><titleStmt><title level="a" type="main" xml:lang="en">Association of a polymorphism in the dopamine‐transporter gene with parkinson's disease</title></titleStmt><publicationStmt><authority>ISTEX</authority><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><availability><p>Wiley Subscription Services, Inc., A Wiley Company</p></availability><date>1997</date></publicationStmt><sourceDesc><biblStruct type="inbook"><analytic><title level="a" type="main" xml:lang="en">Association of a polymorphism in the dopamine‐transporter gene with parkinson's disease</title><author><persName><surname>le Couteur</surname><roleName type="degree">Dr.</roleName></persName><note type="correspondence"><p>Correspondence: Department of Medicine, Princess Alexandra Hospital, Woolloongabba, Q 4102, Australia</p></note><affiliation>University of Queensland, Department of Medicine, Princess Alexandra Hospital, Woolloongabba, Australia</affiliation></author><author><persName><forename type="first">Peter W.</forename><surname>Leighton</surname></persName><affiliation>University of Queensland, Department of Medicine, Princess Alexandra Hospital, Woolloongabba, Australia</affiliation></author><author><persName><forename type="first">Sally J.</forename><surname>McCann</surname></persName><affiliation>University of Queensland, Department of Medicine, Princess Alexandra Hospital, Woolloongabba, Australia</affiliation></author><author><persName><forename type="first">Susan M.</forename><surname>Pond</surname></persName><affiliation>University of Queensland, Department of Medicine, Princess Alexandra Hospital, Woolloongabba, Australia</affiliation></author></analytic><monogr><title level="j">Movement Disorders</title><title level="j" type="sub">Official Journal of the Movement Disorder Society</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="pISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><idno type="DOI">10.1002/(ISSN)1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="1997-09"></date><biblScope unit="vol">12</biblScope><biblScope unit="issue">5</biblScope><biblScope unit="page" from="760">760</biblScope><biblScope unit="page" to="763">763</biblScope></imprint></monogr><idno type="istex">6F1D130494B9C0301723AFA278CEBA9DC1FE54B9</idno><idno type="DOI">10.1002/mds.870120523</idno><idno type="ArticleID">MDS870120523</idno></biblStruct></sourceDesc></fileDesc><profileDesc><creation><date>1997</date></creation><langUsage><language ident="en">en</language></langUsage><abstract xml:lang="en"><p>The presynaptic dopamine transporter in nigral dopaminergic neurons confers susceptibility to the cytotoxic effects of the neurotoxic metabolite of 1‐methy1‐4‐phenyl‐1,2,3,6‐tetrahydropyridine. Polymorphisms in the dopamine transporter might influence the susceptibility to such toxins. Therefore, we investigated whether a polymorphic region in the 3′‐untranslated region of the dopamine‐transporter gene is associated with idiopathic Parkinson's disease (PD). The frequency distribution of the alleles was significantly different between the patients (n = 100) and controls (n = 200, p < 0.05). The rare 11‐copy allele was more common in the patients (odds ratio = 10.2, 95% confidence interval = 1.2‐87.9, p < 0.025). The susceptibility of some people to PD may be conferred by polymorphisms in the dopamine‐transporter gene that could lead to increased cellular accumulation of neurotoxic compounds in dopaminergic neurons.</p></abstract><textClass xml:lang="en"><keywords scheme="keyword"><list><head>Keywords</head><item><term>Parkinson's disease</term></item><item><term>Dopamine transporter</term></item><item><term>Polymorphism</term></item><item><term>Variable‐number tandem repeat</term></item></list></keywords></textClass><textClass><keywords scheme="Journal Subject"><list><head>Article category</head><item><term>Brief Report</term></item></list></keywords></textClass></profileDesc><revisionDesc><change when="1996-10-30">Received</change><change when="1997-01-23">Registration</change><change when="1997-09">Published</change></revisionDesc></teiHeader></istex:fulltextTEI><json:item><original>false</original><mimetype>text/plain</mimetype><extension>txt</extension><uri>https://api.istex.fr/document/6F1D130494B9C0301723AFA278CEBA9DC1FE54B9/fulltext/txt</uri></json:item></fulltext><metadata><istex:metadataXml wicri:clean="Wiley, elements deleted: body"><istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration><istex:document><component version="2.0" type="serialArticle" xml:lang="en"><header><publicationMeta level="product"><publisherInfo><publisherName>Wiley Subscription Services, Inc., A Wiley Company</publisherName><publisherLoc>Hoboken</publisherLoc></publisherInfo><doi registered="yes">10.1002/(ISSN)1531-8257</doi><issn type="print">0885-3185</issn><issn type="electronic">1531-8257</issn><idGroup><id type="product" value="MDS"></id></idGroup><titleGroup><title type="main" xml:lang="en" sort="MOVEMENT DISORDERS">Movement Disorders</title><title type="subtitle">Official Journal of the Movement Disorder Society</title><title type="short">Mov. Disord.</title></titleGroup></publicationMeta><publicationMeta level="part" position="50"><doi origin="wiley" registered="yes">10.1002/mds.v12:5</doi><numberingGroup><numbering type="journalVolume" number="12">12</numbering><numbering type="journalIssue">5</numbering></numberingGroup><coverDate startDate="1997-09">September 1997</coverDate></publicationMeta><publicationMeta level="unit" type="article" position="23" status="forIssue"><doi origin="wiley" registered="yes">10.1002/mds.870120523</doi><idGroup><id type="unit" value="MDS870120523"></id></idGroup><countGroup><count type="pageTotal" number="4"></count></countGroup><titleGroup><title type="articleCategory">Brief Report</title><title type="tocHeading1">Brief Reports</title></titleGroup><copyright ownership="thirdParty">Copyright © 1997 Movement Disorder Society</copyright><eventGroup><event type="manuscriptReceived" date="1996-10-30"></event><event type="manuscriptRevised" date="1997-01-22"></event><event type="manuscriptAccepted" date="1997-01-23"></event><event type="firstOnline" date="2004-11-04"></event><event type="publishedOnlineFinalForm" date="2004-11-04"></event><event type="xmlConverted" agent="Converter:JWSART34_TO_WML3G version:2.3.2 mode:FullText source:HeaderRef result:HeaderRef" date="2010-03-09"></event><event type="xmlConverted" agent="Converter:WILEY_ML3G_TO_WILEY_ML3GV2 version:3.8.8" date="2014-02-02"></event><event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:4.1.7 mode:FullText,remove_FC" date="2014-10-31"></event></eventGroup><numberingGroup><numbering type="pageFirst">760</numbering><numbering type="pageLast">763</numbering></numberingGroup><correspondenceTo>Department of Medicine, Princess Alexandra Hospital, Woolloongabba, Q 4102, Australia</correspondenceTo><linkGroup><link type="toTypesetVersion" href="file:MDS.MDS870120523.pdf"></link></linkGroup></publicationMeta><contentMeta><countGroup><count type="figureTotal" number="0"></count><count type="tableTotal" number="1"></count><count type="referenceTotal" number="30"></count></countGroup><titleGroup><title type="main" xml:lang="en">Association of a polymorphism in the dopamine‐transporter gene with parkinson's disease</title><title type="short" xml:lang="en">PARKINSON'S DISEASE AND THE DOPAMINE TRANSPORTER</title></titleGroup><creators><creator xml:id="au1" creatorRole="author" affiliationRef="#af1" corresponding="yes"><personName><honorifics>Dr.</honorifics><givenNames>David G.</givenNames><familyName>le Couteur</familyName></personName></creator><creator xml:id="au2" creatorRole="author" affiliationRef="#af1"><personName><givenNames>Peter W.</givenNames><familyName>Leighton</familyName></personName></creator><creator xml:id="au3" creatorRole="author" affiliationRef="#af1"><personName><givenNames>Sally J.</givenNames><familyName>McCann</familyName></personName></creator><creator xml:id="au4" creatorRole="author" affiliationRef="#af1"><personName><givenNames>Susan M.</givenNames><familyName>Pond</familyName></personName></creator></creators><affiliationGroup><affiliation xml:id="af1" countryCode="AU" type="organization"><unparsedAffiliation>University of Queensland, Department of Medicine, Princess Alexandra Hospital, Woolloongabba, Australia</unparsedAffiliation></affiliation></affiliationGroup><keywordGroup xml:lang="en" type="author"><keyword xml:id="kwd1">Parkinson's disease</keyword><keyword xml:id="kwd2">Dopamine transporter</keyword><keyword xml:id="kwd3">Polymorphism</keyword><keyword xml:id="kwd4">Variable‐number tandem repeat</keyword></keywordGroup><abstractGroup><abstract type="main" xml:lang="en"><title type="main">Abstract</title><p>The presynaptic dopamine transporter in nigral dopaminergic neurons confers susceptibility to the cytotoxic effects of the neurotoxic metabolite of 1‐methy1‐4‐phenyl‐1,2,3,6‐tetrahydropyridine. Polymorphisms in the dopamine transporter might influence the susceptibility to such toxins. Therefore, we investigated whether a polymorphic region in the 3′‐untranslated region of the dopamine‐transporter gene is associated with idiopathic Parkinson's disease (PD). The frequency distribution of the alleles was significantly different between the patients (n = 100) and controls (n = 200, p < 0.05). The rare 11‐copy allele was more common in the patients (odds ratio = 10.2, 95% confidence interval = 1.2‐87.9, p < 0.025). The susceptibility of some people to PD may be conferred by polymorphisms in the dopamine‐transporter gene that could lead to increased cellular accumulation of neurotoxic compounds in dopaminergic neurons.</p></abstract></abstractGroup></contentMeta></header></component></istex:document></istex:metadataXml><!--Version 0.6 générée le 3-12-2015--><mods version="3.6"><titleInfo lang="en"><title>Association of a polymorphism in the dopamine‐transporter gene with parkinson's disease</title></titleInfo><titleInfo type="abbreviated" lang="en"><title>PARKINSON'S DISEASE AND THE DOPAMINE TRANSPORTER</title></titleInfo><titleInfo type="alternative" contentType="CDATA" lang="en"><title>Association of a polymorphism in the dopamine‐transporter gene with parkinson's disease</title></titleInfo><name type="personal"><namePart type="termsOfAddress">Dr.</namePart><namePart type="family">le Couteur</namePart><affiliation>University of Queensland, Department of Medicine, Princess Alexandra Hospital, Woolloongabba, Australia</affiliation><description>Correspondence: Department of Medicine, Princess Alexandra Hospital, Woolloongabba, Q 4102, Australia</description><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Peter W.</namePart><namePart type="family">Leighton</namePart><affiliation>University of Queensland, Department of Medicine, Princess Alexandra Hospital, Woolloongabba, Australia</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Sally J.</namePart><namePart type="family">McCann</namePart><affiliation>University of Queensland, Department of Medicine, Princess Alexandra Hospital, Woolloongabba, Australia</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Susan M.</namePart><namePart type="family">Pond</namePart><affiliation>University of Queensland, Department of Medicine, Princess Alexandra Hospital, Woolloongabba, Australia</affiliation><role><roleTerm type="text">author</roleTerm></role></name><typeOfResource>text</typeOfResource><genre authority="originalCategForm">article</genre><originInfo><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><place><placeTerm type="text">Hoboken</placeTerm></place><dateIssued encoding="w3cdtf">1997-09</dateIssued><dateCaptured encoding="w3cdtf">1996-10-30</dateCaptured><dateValid encoding="w3cdtf">1997-01-23</dateValid><copyrightDate encoding="w3cdtf">1997</copyrightDate></originInfo><language><languageTerm type="code" authority="rfc3066">en</languageTerm><languageTerm type="code" authority="iso639-2b">eng</languageTerm></language><physicalDescription><internetMediaType>text/html</internetMediaType><extent unit="tables">1</extent><extent unit="references">30</extent></physicalDescription><abstract lang="en">The presynaptic dopamine transporter in nigral dopaminergic neurons confers susceptibility to the cytotoxic effects of the neurotoxic metabolite of 1‐methy1‐4‐phenyl‐1,2,3,6‐tetrahydropyridine. Polymorphisms in the dopamine transporter might influence the susceptibility to such toxins. Therefore, we investigated whether a polymorphic region in the 3′‐untranslated region of the dopamine‐transporter gene is associated with idiopathic Parkinson's disease (PD). The frequency distribution of the alleles was significantly different between the patients (n = 100) and controls (n = 200, p < 0.05). The rare 11‐copy allele was more common in the patients (odds ratio = 10.2, 95% confidence interval = 1.2‐87.9, p < 0.025). The susceptibility of some people to PD may be conferred by polymorphisms in the dopamine‐transporter gene that could lead to increased cellular accumulation of neurotoxic compounds in dopaminergic neurons.</abstract><subject lang="en"><genre>Keywords</genre><topic>Parkinson's disease</topic><topic>Dopamine transporter</topic><topic>Polymorphism</topic><topic>Variable‐number tandem repeat</topic></subject><relatedItem type="host"><titleInfo><title>Movement Disorders</title><subTitle>Official Journal of the Movement Disorder Society</subTitle></titleInfo><titleInfo type="abbreviated"><title>Mov. Disord.</title></titleInfo><subject><genre>article category</genre><topic>Brief Report</topic></subject><identifier type="ISSN">0885-3185</identifier><identifier type="eISSN">1531-8257</identifier><identifier type="DOI">10.1002/(ISSN)1531-8257</identifier><identifier type="PublisherID">MDS</identifier><part><date>1997</date><detail type="volume"><caption>vol.</caption><number>12</number></detail><detail type="issue"><caption>no.</caption><number>5</number></detail><extent unit="pages"><start>760</start><end>763</end><total>4</total></extent></part></relatedItem><identifier type="istex">6F1D130494B9C0301723AFA278CEBA9DC1FE54B9</identifier><identifier type="DOI">10.1002/mds.870120523</identifier><identifier type="ArticleID">MDS870120523</identifier><accessCondition type="use and reproduction" contentType="copyright">Copyright © 1997 Movement Disorder Society</accessCondition><recordInfo><recordOrigin>Wiley Subscription Services, Inc., A Wiley Company</recordOrigin><recordContentSource>WILEY</recordContentSource></recordInfo></mods></metadata><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003203 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 003203 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= Istex
|étape= Corpus
|type= RBID
|clé= ISTEX:6F1D130494B9C0301723AFA278CEBA9DC1FE54B9
|texte= Association of a polymorphism in the dopamine‐transporter gene with parkinson's disease
}}
| This area was generated with Dilib version V0.6.23. |  |